Literature DB >> 20013193

Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease.

Paula I Moreira1, Lawrence M Sayre, Xiongwei Zhu, Akihiko Nunomura, Mark A Smith, George Perry.   

Abstract

Oxidative stress is a key factor involved in the development and progression of Alzheimer disease (AD), and it is well documented that free radical oxidative damage, particularly of neuronal lipids, proteins, nucleic acids, and sugars, is extensive in brains of AD patients. The complex chemistry of peroxynitrite has been the subject of intense study and is now evident that there are two principal pathways for protein modification: the first one involves homolytic hydroxyl radical-like chemistry that results in protein-based carbonyls and the second involves electrophilic nitration of vulnerable side chains, in particular the electron-rich aromatic rings of Tyr and Trp. In the presence of buffering bicarbonate, peroxynitrite forms a CO(2) adduct, which augments its reactivity. Formation of 3-nitrotyrosine by this route has become the classical protein marker specifically for the presence of peroxynitrite. Protein-based carbonyls can be detected by two methods: (i) derivatization with 2,4-dinitrophenylhydrazine (DNPH) and detection of the protein-bound hydrazones using an enzyme-linked anti-2,4-dinitrophenyl antibody and (ii) derivatization with biotin-hydrazide and detection of the protein-bound acyl hydrazone with enzyme-linked avidin or streptavidin. Glycation of proteins by reducing sugars (Maillard reaction) results in a profile of time-dependent adduct evolution rendering susceptibility to oxidative elaboration. In addition, oxidative stress can result in oxidized sugar derivatives which can subsequently modify protein through a process known as glycoxidation. Of more general importance, oxidative stress results in lipid peroxidation and the production of a range of electrophilic and mostly bifunctional aldehydes that modify numerous proteins. The more important protein modifications are referred to as advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs). Protein modification can result in both non-cross-link and cross-link AGEs and ALEs, the latter arising from the potential bifunctional reactivity, such as that of the lipid-derived modifiers 4-hydroxy-2-nonenal (HNE) and malondialdehyde (MDA). Oxidative damage to nucleic acids results in base modification, substitutions, and deletions. Among the most common modifications, 8-hydroxyguanosine (8OHG) is considered a signature of oxidative damage to nucleic acid.Cells are not passive to increased oxygen radical production but rather upregulate protective responses. In neurodegenerative diseases, heme oxygenase-1 (HO-1) induction is coincident with the formation of neurofibrillary tangles. This enzyme that converts heme, a prooxidant, to biliverdin/bilirubin (antioxidants) and free iron has been considered an antioxidant enzyme. But seen in the context of arresting apoptosis, HO-1 and tau may play a role in maintaining the neurons free from the apoptotic signal (cytochrome c), since tau has strong iron-binding sites. Given the importance of iron as a catalyst for the generation of reactive oxygen species, changes in proteins associated with iron homeostasis can be used as an index of cellular responses. One such class of proteins is the iron regulatory proteins (IRPs) that respond to cellular iron concentrations by regulating the translation of proteins involved in iron uptake, storage, and utilization. Therefore, IRPs are considered to be the central control components of cellular iron concentration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20013193      PMCID: PMC5914163          DOI: 10.1007/978-1-60327-029-8_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  34 in total

1.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

2.  A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain.

Authors:  D N Posnett; H McGrath; J P Tam
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

3.  Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline.

Authors:  S Miyata; V Monnier
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

4.  Oxidative damage is the earliest event in Alzheimer disease.

Authors:  A Nunomura; G Perry; G Aliev; K Hirai; A Takeda; E K Balraj; P K Jones; H Ghanbari; T Wataya; S Shimohama; S Chiba; C S Atwood; R B Petersen; M A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

5.  Widespread peroxynitrite-mediated damage in Alzheimer's disease.

Authors:  M A Smith; P L Richey Harris; L M Sayre; J S Beckman; G Perry
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

6.  Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta.

Authors:  R K Kutty; C N Nagineni; G Kutty; J J Hooks; G J Chader; B Wiggert
Journal:  J Cell Physiol       Date:  1994-05       Impact factor: 6.384

Review 7.  Oxidative stress signalling in Alzheimer's disease.

Authors:  Xiongwei Zhu; Arun K Raina; Hyoung-Gon Lee; Gemma Casadesus; Mark A Smith; George Perry
Journal:  Brain Res       Date:  2004-03-12       Impact factor: 3.252

8.  Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease.

Authors:  P Cras; M A Smith; P L Richey; S L Siedlak; P Mulvihill; G Perry
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Differential regulation of two related RNA-binding proteins, iron regulatory protein (IRP) and IRPB.

Authors:  K Pantopoulos; N K Gray; M W Hentze
Journal:  RNA       Date:  1995-04       Impact factor: 4.942

10.  Analysis of microtubule-associated protein tau glycation in paired helical filaments.

Authors:  M D Ledesma; P Bonay; C Colaço; J Avila
Journal:  J Biol Chem       Date:  1994-08-26       Impact factor: 5.157

View more
  23 in total

1.  Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease.

Authors:  R Derungs; G G Camici; R D Spescha; T Welt; C Tackenberg; C Späni; F Wirth; A Grimm; A Eckert; R M Nitsch; L Kulic
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

Review 2.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

Review 3.  Iron chelation and neuroprotection in neurodegenerative diseases.

Authors:  Xuping Li; Joseph Jankovic; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

Review 4.  Ubiquitin carboxyl-terminal hydrolase L-1 in brain: Focus on its oxidative/nitrosative modification and role in brains of subjects with Alzheimer disease and mild cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2021-11-01       Impact factor: 7.376

5.  X-ray induced cataract is preceded by LEC loss, and coincident with accumulation of cortical DNA, and ROS; similarities with age-related cataracts.

Authors:  William Pendergrass; Galynn Zitnik; Ryan Tsai; Norman Wolf
Journal:  Mol Vis       Date:  2010-08-06       Impact factor: 2.367

6.  Ablation of the locus coeruleus increases oxidative stress in tg-2576 transgenic but not wild-type mice.

Authors:  Orest Hurko; Kurt Boudonck; Cathleen Gonzales; Zoe A Hughes; J Steve Jacobsen; Peter H Reinhart; Daniel Crowther
Journal:  Int J Alzheimers Dis       Date:  2010-10-11

7.  Timosaponin B-II ameliorates scopolamine-induced cognition deficits by attenuating acetylcholinesterase activity and brain oxidative damage in mice.

Authors:  Xu Zhao; Chunmei Liu; Yu Qi; Lina Fang; Jie Luo; Kaishun Bi; Ying Jia
Journal:  Metab Brain Dis       Date:  2016-07-22       Impact factor: 3.584

Review 8.  The use of the Cre/loxP system to study oxidative stress in tissue-specific manganese superoxide dismutase knockout models.

Authors:  John C Marecki; Nirmala Parajuli; John P Crow; Lee Ann MacMillan-Crow
Journal:  Antioxid Redox Signal       Date:  2013-06-20       Impact factor: 8.401

Review 9.  Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?

Authors:  Greg T Sutherland; Belal Chami; Priscilla Youssef; Paul K Witting
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

10.  Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system.

Authors:  Astrid Bottelbergs; Simon Verheijden; Paul P Van Veldhoven; Wilhelm Just; Rita Devos; Myriam Baes
Journal:  J Neuroinflammation       Date:  2012-03-29       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.